A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.
Clinical trial NCT02281773 · COMPLETED
Trial details
- NCT number
- NCT02281773
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-10
- Primary completion
- 2016-05-26
- Enrollment
- 518
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.